200
Participants
Start Date
July 31, 2014
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
dexamethasone 700 ㎍ intravitreal implant
Patients who receive dexamethasone 700 ㎍ (OZURDEX®) intravitreal implant treatment for Diabetic Macular Edema. All decisions regarding treatment are made at the sole discretion of the treating physician in accordance with their usual practices.
Long Island Vitreoretinal Consultants - Long Island Retina - Hauppauge, Great Neck
Mid Atlantic Retina, Philadelphia
Raj Maturi, MD PC, Indianapolis
John-Kenyon American Eye Institute, New Albany
Associated Retina Consultants, Royal Oak
Illinois Retina Associates, Harvey
Lifelong Vision Foundation, Chesterfield
Associated Retinal Consultants, PC, Traverse City
Texas Retina Associates, Arlington, Arlington
Medical Center Ophthalmology Associates, San Antonio
Valley Retina Institute, P.A., McAllen
Colorado Retina Associates, Denver
Retinal Consultants of Phoenix, Phoenix
Orange Co Retina Medical Group, Santa Ana
West Coast Retina, San Francisco
Bay Area Retina Associates, Walnut Creek
Eyesight Ophthalmic Services, Portsmouth
New Jersey Retina, New Brunswick
Lead Sponsor
Allergan
INDUSTRY